BioCatch vs Signzy

BioCatch has a disclosed valuation of $1B, while Signzy's valuation is not publicly available, making a direct size comparison difficult. BioCatch employs 100-500 people.

BioCatch has raised more in total funding at $213M, compared to Signzy's $26M — a gap of $187M.

BioCatch holds the higher Awaira Score at 80/100, compared to Signzy's 63/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 17-point gap that reflects meaningful differences in scale or traction.

BioCatch was founded by Avi Turgeman in 2011. Signzy was founded by Nikhil Idnani in 2015. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. Signzy: Signzy is a digital identity verification and KYC automation platform that uses AI-powered document analysis, liveness detection, and database integration to enable financial institutions and regulated businesses to onboard customers remotely with regulatory compliance. The platform processes identity documents, conducts video KYC, and provides risk scoring through APIs that integrate with banking and fintech onboarding workflows.\n\nThe company raised approximately $26M in Series B funding from investors including Vertex Ventures and Arkam Ventures, and serves a large base of banks, NBFCs, insurance companies, and fintech platforms in India. Signzy processed tens of millions of KYC verifications and has been recognized by the Reserve Bank of India for its video KYC framework contributions.\n\nVideo KYC and digital identity verification have become mandatory for regulated financial services in India, creating a large and recurring market for compliant identity infrastructure. Signzy's deep regulatory expertise and production track record across India's financial system give it a significant advantage over generic identity verification platforms that lack India-specific compliance depth.

BioCatch was founded first in 2011, giving it 4 years of additional market experience. Signzy was founded later in 2015. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.

BioCatch has approximately 100-500 employees, while Signzy has approximately 200-500. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.

Yes, BioCatch and Signzy are direct competitors — both operate in the AI Security space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.